|Non Small Cell Lung Cancer||49||Spain||2015||currently in treatment|
Alicia, Non Small Cell Lung Cancer
|49||Spain||2015||currently in treatment|
In 2015 the patient was diagnosed with a NSCLC stage IV.
Alicia was diagnosed with lung cancer in January 2015.
Biomarkers already tested:
– EGFR: NEGATIVE
– ALK: NEGATIVE
– ROS1: pending result
Both the patient her oncologist agreed to do an OncoDEEP testing. Fusion panel : identification of ROS1 fusion.
Recommended treatments :
– ALK expression inhibitors
Based on the results generated with OncoDEEP, the oncologist decided to treat the patient with crizotinib.
After more than one year and a half, the patient is in partial response without any tolerability issues allowing her to have a normal life.
Dr Carlos CAMPS HERRERO
We found a very rare alteration that has tremendously changed patient’s quality of life.